Table of Contents

1 Study Coverage

• 1.1 Brain Edema Treatment Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Brain Edema Treatment Market Size Growth Rate by Product
  • 1.4.2 PMZ-2123
  • 1.4.3 FG-4497
  • 1.4.4 Glyburide
  • 1.4.5 Others
• 1.5 Market by End User
  • 1.5.1 Global Brain Edema Treatment Market Size Growth Rate by End User
  • 1.5.2 Clinic
  • 1.5.3 Hospital
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Brain Edema Treatment Market Size
  • 2.1.1 Global Brain Edema Treatment Revenue 2014-2025
  • 2.1.2 Global Brain Edema Treatment Sales 2014-2025
• 2.2 Brain Edema Treatment Growth Rate by Regions
  • 2.2.1 Global Brain Edema Treatment Sales by Regions
  • 2.2.2 Global Brain Edema Treatment Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Brain Edema Treatment Sales by Manufacturers
  • 3.1.1 Brain Edema Treatment Sales by Manufacturers
  • 3.1.2 Brain Edema Treatment Sales Market Share by Manufacturers
  • 3.1.3 Global Brain Edema Treatment Market Concentration Ratio (CR5 and HHI)
• 3.2 Brain Edema Treatment Revenue by Manufacturers
  • 3.2.1 Brain Edema Treatment Revenue by Manufacturers (2014-2019)
  • 3.2.2 Brain Edema Treatment Revenue Share by Manufacturers (2014-2019)
• 3.3 Brain Edema Treatment Price by Manufacturers
• 3.4 Brain Edema Treatment Manufacturing Base Distribution, Product Types
  • 3.4.1 Brain Edema Treatment Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Brain Edema Treatment Product Type
  • 3.4.3 Date of International Manufacturers Enter into Brain Edema Treatment Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Brain Edema Treatment Sales by Product
• 4.2 Global Brain Edema Treatment Revenue by Product
• 4.3 Brain Edema Treatment Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Brain Edema Treatment Breakdown Data by End User

6 North America

• 6.1 North America Brain Edema Treatment by Countries
  • 6.1.1 North America Brain Edema Treatment Sales by Countries
  • 6.1.2 North America Brain Edema Treatment Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Brain Edema Treatment by Product
• 6.3 North America Brain Edema Treatment by End User

7 Europe

• 7.1 Europe Brain Edema Treatment by Countries
  • 7.1.1 Europe Brain Edema Treatment Sales by Countries
  • 7.1.2 Europe Brain Edema Treatment Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Brain Edema Treatment by Product
• 7.3 Europe Brain Edema Treatment by End User

8 Asia Pacific

• 8.1 Asia Pacific Brain Edema Treatment by Countries
  • 8.1.1 Asia Pacific Brain Edema Treatment Sales by Countries
  • 8.1.2 Asia Pacific Brain Edema Treatment Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Brain Edema Treatment by Product
• 8.3 Asia Pacific Brain Edema Treatment by End User

9 Central & South America

• 9.1 Central & South America Brain Edema Treatment by Countries
  • 9.1.1 Central & South America Brain Edema Treatment Sales by Countries
  • 9.1.2 Central & South America Brain Edema Treatment Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Brain Edema Treatment by Product
• 9.3 Central & South America Brain Edema Treatment by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Brain Edema Treatment by Countries
  • 10.1.1 Middle East and Africa Brain Edema Treatment Sales by Countries
  • 10.1.2 Middle East and Africa Brain Edema Treatment Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Brain Edema Treatment by Product
• 10.3 Middle East and Africa Brain Edema Treatment by End User

11 Company Profiles

• 11.1 FibroGen Inc
  • 11.1.1 FibroGen Inc Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 FibroGen Inc Brain Edema Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 FibroGen Inc Brain Edema Treatment Products Offered
  • 11.1.5 FibroGen Inc Recent Development
• 11.2 Pharmazz Inc
  • 11.2.1 Pharmazz Inc Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Pharmazz Inc Brain Edema Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Pharmazz Inc Brain Edema Treatment Products Offered
  • 11.2.5 Pharmazz Inc Recent Development
• 11.3 Remedy Pharmaceuticals Inc
  • 11.3.1 Remedy Pharmaceuticals Inc Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Remedy Pharmaceuticals Inc Brain Edema Treatment Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Remedy Pharmaceuticals Inc Brain Edema Treatment Products Offered
  • 11.3.5 Remedy Pharmaceuticals Inc Recent Development

12 Future Forecast

• 12.1 Brain Edema Treatment Market Forecast by Regions
  • 12.1.1 Global Brain Edema Treatment Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Brain Edema Treatment Revenue Forecast by Regions 2019-2025
• 12.2 Brain Edema Treatment Market Forecast by Product
  • 12.2.1 Global Brain Edema Treatment Sales Forecast by Product 2019-2025
  • 12.2.2 Global Brain Edema Treatment Revenue Forecast by Product 2019-2025
• 12.3 Brain Edema Treatment Market Forecast by End User
• 12.4 North America Brain Edema Treatment Forecast
• 12.5 Europe Brain Edema Treatment Forecast
• 12.6 Asia Pacific Brain Edema Treatment Forecast
• 12.7 Central & South America Brain Edema Treatment Forecast
• 12.8 Middle East and Africa Brain Edema Treatment Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Brain Edema Treatment Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

The global Brain Edema Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Edema Treatment market based on company, product type, end user and key regions.

This report studies the global market size of Brain Edema Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Brain Edema Treatment in these regions.
This research report categorizes the global Brain Edema Treatment market by top players/brands, region, type and end user. This report also studies the global Brain Edema Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
FibroGen Inc
Pharmazz Inc
Remedy Pharmaceuticals Inc

Market size by Product
PMZ-2123
FG-4497
Glyburide
Others
Market size by End User
Clinic
Hospital
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Brain Edema Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Brain Edema Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Brain Edema Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Brain Edema Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Brain Edema Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Brain Edema Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.